Hepatitis C virus (HCV)-induced IgG-IgM rheumatoid factor (RF) complex may be the main causal factor for cold-dependent activation of complement in patients with rheumatic disease

Clinical and Experimental Immunology

Volumn 107, Issue 1, 1997, Pages 83-88

  Wei, G ^a   Yano, S ^a   Kuroiwa, T ^a   Hiromura, K ^a   Maezawa, A ^a  

^a GUNMA UNIVERSITY   (Japan)

Author keywords

CH50; Cryoglobulin like substance; HCV infection; In vitro activation; Rheumatic disease

Indexed keywords

COMPLEMENT COMPONENT C3; COMPLEMENT COMPONENT C4; CRYOGLOBULIN; IMMUNOGLOBULIN G; IMMUNOGLOBULIN M; RHEUMATOID FACTOR;

ADULT; AGED; ARTICLE; COMPLEMENT ACTIVATION; CONTROLLED STUDY; FEMALE; HEPATITIS C VIRUS; HUMAN; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RHEUMATIC DISEASE; SYSTEMIC LUPUS ERYTHEMATOSUS;

EID: 0031025560     PISSN: 00099104     EISSN: None     Source Type: Journal    
DOI: 10.1046/j.1365-2249.1997.d01-882.x     Document Type: Article

References (30)

1. Gewurz H. Nonimmune activation of C: Two new phenomena. J Immunol 1973; 111:305.
2. Glovsky MM, Alenty A. Coagulation related deficiencies of early components of C (C1, C4, C2) in human serum. J Immunol 1973; 111:305.
3. Gewurz H, Baron J, Ratnoff OD. Coagulation associated consumption of complement: a case with dissociation between serum and plasma complement activites. J Clin Invest 1970; 49:33a.
4. Van Royen EA, Lohman S. C1 inactivator and cold-promoted activation of factor VII. J Lab Clin Med 1978; 92:152-63.
5. Palmer Richard N, Gralnick Harvey R. Cold-induced contact surface activation of the prothrombin time in whole blood. Blood 1982; 59:38-42.
6. Kondo M, Hosokawa K. Cold activation of complement. I. Presence of coagulation-related activator. J Immunol 1976; 117:486-90.
7. Kondo M, Takemura S. Cold activation of complement and kinin. Adv Exp Med Biol 1979; 120B:133-8.
8. Akagaki Y, Fujiwara Y. The difference between serum and plasma complement activity in primary renal disease. Clin Nephrol 1980; 14:75-80.
9. Fujimoto S, Hirayama N. Horseshoe kidney and membranous glomerulonephritis with cold activation of complement. Intern Med 1992;31:625-8.
10. Inai S, Kitamura H. Difference between plasma and serum complement in patients with chronic liver disease. Clin Exp Immunol 1976; 25:403-9.
11. Kitamura H, Nagaki K. The cold activation of the classical complement pathway: the cause of the differences between plasma and serum complement in liver cirrhosis. Clin Exp Immunol 1977; 27:34-37.
12. Atkinson John P, Gorman John C. Cold dependent activation of complement in systemic lupus erythematosus. Arthritis Rheum 1981; 24:592-601.
13. Takemura S, Hotta T. Cold activation of complement. Arthritis Rheum 1982; 25:1138-40.
14. Mathews Kenneth P, Mentyka Robert A. Cold-dependent activation of complement: recognition, assessment, and mechanism. J Clin Immunol 1992; 12:362-70.
15. Takemura S, Kondo M. Hemolytic complement activity via classical pathway (CH50). Japan Clin 1990; 48:634-6.
16. Ueda K, Nakajima H. The association between hepatitis C virus infection and in vitro activation of the complement system. Ann Clin Biochem 1993; 30:565-9.
17. Itoh K, Tanaka H. Hypocomplementemia associated with hepatitis C viremia in sera from voluntary blood donors. Am J Gastroenterol 1994; 89:2019-24.
18. Nakagawa T, Ueda K. RH and cyoglobulin are not efficiently related to cold activation of complement. Japan Clin Pathol 1995; 43:21-25.
19. Cacoub P, Musset L. Hepatitis C virus and essential mixed cyoglobulinaemia. Br J Rheumatol 1993; 32:689-92.
20. Kitamura H. A simple procedure for the titration of total hemolytic complement activity - one point method. Japan Clin Chem 1983; 12:143.
21. Mancini G. Immunochemical quantitation of antigens by single radial immunodiriusion. Immunochemistry 1965; 2:235.
22. Choo QL, Kuo G. Isolation of a cDNA clone derived from a blood-borne non-A, non-B viral hepatitis genome. Science 1989; 244:359-62.
23. Lau JYN, Davis GL. Significance of serum hepatitis C virus RNA levels in chronic hepatitis C. Lancet 1993; 341:1501-4.
24. Guss B, Eliasson M. Structure of the IgG-binding regions of streptococcal protein G. EMBO J 1986; 5:1567-75.
25. Akerstrom B, Brodin T. Protein G: a powerful tool for binding and detection of monoclonal and polyclonal antibodies. J Immunol 1985; 135:2589-92.
26. Katakam M, Banga Ajay K. Aggregation of proteins and its prevention by carbohydrate excipients: albumins and γ-globulin. J Pharm Pharmacol 1995; 47:103-7.
27. Laemmli UK. Cleavage of structural proteins during the assemble of bacteriophage T4. Nature 1970; 227:680-5.
28. Towbin H, Staehelin T. Electrophoretic transfer of proteins from polyacrylamide gels to nitrocellulose sheets: procedure and some applications. Proc Natl Acad Sci USA 1979; 76:4350-4.
29. Newell Sara, Gorman John C. Hemolytic and antigenic measurements of complement: a comparison of serum and plasma samples in normal individuals and patients. J Lab Clin Med 1982; 100:437-44.
30. Maillet F, Fremeaux Bacchi V. Assessment of complement activation in clinical samples: comparison of immunochemical and functional measurements of complement components with quantitation of activation fragments. J Immunol Methods 1992; 156:171-8.